These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12576419)

  • 41. Influence of eicosapentaenoic acid, an omega-3 fatty acid, on ultraviolet-B generation of prostaglandin-E2 and proinflammatory cytokines interleukin-1 beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-8 in human skin in vivo.
    Shahbakhti H; Watson RE; Azurdia RM; Ferreira CZ; Garmyn M; Rhodes LE
    Photochem Photobiol; 2004; 80(2):231-5. PubMed ID: 15362934
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
    Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systemic inflammatory response after extremity or truncal fracture operations.
    Pape HC; Griensven MV; Hildebrand FF; Tzioupis CT; Sommer KL; Krettek CC; Giannoudis PV;
    J Trauma; 2008 Dec; 65(6):1379-84. PubMed ID: 19077630
    [TBL] [Abstract][Full Text] [Related]  

  • 44. N-acetyl-B-D-glucosaminidase and inflammatory response after cardiopulmonary bypass.
    Iqbal MP; Sharif HM; Mehboobali N; Yousuf FA; Khan AH; Sellke FW
    J Coll Physicians Surg Pak; 2008 Feb; 18(2):74-7. PubMed ID: 18454889
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of preoperative statin therapy on cytokines after cardiac surgery.
    Liakopoulos OJ; Dörge H; Schmitto JD; Nagorsnik U; Grabedünkel J; Schoendube FA
    Thorac Cardiovasc Surg; 2006 Jun; 54(4):250-4. PubMed ID: 16755446
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The value of plasma cytokine measurement for the detection of strangulation in patients with bowel obstruction: a prospective, pilot study.
    Yamamoto T; Umegae S; Kitagawa T; Matsumoto K
    Dis Colon Rectum; 2005 Jul; 48(7):1451-9. PubMed ID: 15868224
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Time course of inflammatory response after renal artery stenting in patients with atherosclerotic renal stenosis.
    Li JJ; Fang CH; Jiang H; Huang CX; Hui RT; Chen MZ
    Clin Chim Acta; 2004 Dec; 350(1-2):115-21. PubMed ID: 15530467
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevated level of interleukin-6 predicts organ failure and severe disease in patients with acute pancreatitis.
    Sathyanarayan G; Garg PK; Prasad H; Tandon RK
    J Gastroenterol Hepatol; 2007 Apr; 22(4):550-4. PubMed ID: 17376050
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevated concentrations of monocyte derived cytokines in synovial fluid of children with enthesitis related arthritis and polyarticular types of juvenile idiopathic arthritis.
    Saxena N; Aggarwal A; Misra R
    J Rheumatol; 2005 Jul; 32(7):1349-53. PubMed ID: 15996076
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IL-18 is involved in vascular injury in end-stage renal disease patients.
    Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
    Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aggressive periodontitis and chronic arthritis: blood mononuclear cell gene expression and plasma protein levels of cytokines and cytokine inhibitors.
    Sørensen LK; Havemose-Poulsen A; Bendtzen K; Holmstrup P
    J Periodontol; 2009 Feb; 80(2):282-9. PubMed ID: 19186969
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The cyclin-dependent kinase inhibitor flavopiridol potentiates gamma-irradiation-induced apoptosis in colon and gastric cancer cells.
    Jung C; Motwani M; Kortmansky J; Sirotnak FM; She Y; Gonen M; Haimovitz-Friedman A; Schwartz GK
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6052-61. PubMed ID: 14676132
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Urine interleukin-8 as a marker of vesicoureteral reflux in infants.
    Galanakis E; Bitsori M; Dimitriou H; Giannakopoulou C; Karkavitsas NS; Kalmanti M
    Pediatrics; 2006 May; 117(5):e863-7. PubMed ID: 16585276
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endocrine stress response and inflammatory activation during CABG surgery. A randomized trial comparing remifentanil infusion to intermittent fentanyl.
    Winterhalter M; Brandl K; Rahe-Meyer N; Osthaus A; Hecker H; Hagl C; Adams HA; Piepenbrock S
    Eur J Anaesthesiol; 2008 Apr; 25(4):326-35. PubMed ID: 18005471
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridol.
    Thomas JP; Tutsch KD; Cleary JF; Bailey HH; Arzoomanian R; Alberti D; Simon K; Feierabend C; Binger K; Marnocha R; Dresen A; Wilding G
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):465-72. PubMed ID: 12451473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Release of proinflammatory cytokines related to luteolysis and the periparturient acute phase response in prostaglandin-induced parturition in cows.
    Koets AP; de Schwartz N; Tooten P; Kankofer M; Broekhuijsen-Davies JM; Rutten VP; van Leengoed LA; Taverne MA; Gruys E
    Theriogenology; 1998 Mar; 49(4):797-812. PubMed ID: 10732088
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Flavopiridol, a cyclin-dependent kinase inhibitor].
    Lansiaux A; Bailly C
    Bull Cancer; 2000 Oct; 87(10):697-701. PubMed ID: 11084532
    [No Abstract]   [Full Text] [Related]  

  • 58. A dose-finding, pharmacokinetic and pharmacodynamic study of a novel schedule of flavopiridol in patients with advanced solid tumors.
    Ramaswamy B; Phelps MA; Baiocchi R; Bekaii-Saab T; Ni W; Lai JP; Wolfson A; Lustberg ME; Wei L; Wilkins D; Campbell A; Arbogast D; Doyle A; Byrd JC; Grever MR; Shah MH
    Invest New Drugs; 2012 Apr; 30(2):629-38. PubMed ID: 20938713
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Flavopiridol: the first cyclin-dependent kinase inhibitor in human clinical trials.
    Senderowicz AM
    Invest New Drugs; 1999; 17(3):313-20. PubMed ID: 10665481
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transient increase of plasma interleukin-6 after infusion of recombinant tumor necrosis factor alpha in advanced cancer patients.
    Zubelewicz B; Romanowski W; Braczkowska B; Lissoni P; Braczkowski R
    J Exp Clin Cancer Res; 1998 Dec; 17(4):449-52. PubMed ID: 10089067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.